Clin2
NCT07493629Possibly a fitRecruiting

Study on immune status and disease control in inflammatory airway diseases

Airway InflammationChronic Obstructive Pulmonary Disease (COPD)Asthma (Diagnosis)BronchiectasisOSAS (Obstructive Sleep Apneas Syndrome)Allergic Bronchopulmonary Aspergillosis (ABPA)

Part of Brain & nervous system, Immune system & allergy, Infections, Lungs & breathing clinical trials.

This study looks at how the immune system works and how well diseases like asthma, COPD, and others are controlled. You may join if you have one of these conditions or if you are a healthy volunteer or smoker without lung disease.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
200 people
Ages
18 years and older
Study type
Observational

Who can take part

  • You are 18 or older (40 or older if you have COPD)
  • You have been diagnosed with asthma, COPD, bronchiectasis, allergic bronchopulmonary aspergillosis (ABPA), or obstructive sleep apnea (OSAS) by your doctor
  • Or you are a smoker with at least 10 pack-years of smoking history and normal lung function with no chronic breathing symptoms
  • Or you are healthy with normal lung function, low exhaled nitric oxide (FeNO <20 ppb), low allergy marker (total IgE <100 IU/mL), no chronic disease, smoked less than 10 pack-years, and have not used immune-suppressing drugs in the past 3 months
  • You have not had a sudden worsening of your lung disease in the past 4 weeks, and you have not used antibiotics, antifungal drugs, immune-suppressing drugs, or high-dose steroids (except for ongoing maintenance therapy)
  • You are not pregnant or breastfeeding, and you do not have serious other health problems like heart attack, severe irregular heartbeat, liver or kidney failure, blood disorders, or active cancer

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06685315Not yet recruiting
Study of chronic airway diseases (asthma, COPD)

This study looks at chronic airway diseases like asthma and COPD. Researchers want to learn more about how these conditions affect people and may explore treatments. You might join if you have asthma or COPD and no other major health issues.

NCT07472738Recruiting
Studying treatable traits in chronic airway diseases

This trial is studying people with chronic lung conditions, like COPD or asthma, to find treatable traits. It also includes healthy volunteers for comparison, to better understand what makes these diseases different and how to personalize treatment.

Beijing, Beijing Municipality
NCT07274631Recruiting
Study of inflammatory lung diseases

This study collects information from people with various inflammatory lung conditions, like asthma or COPD, to better understand them and improve treatment. Healthy volunteers are also needed for comparison.

Reims
NCT06938022Not yet recruiting
Study on lung infection and imaging in chronic airway patients

This study looks at the bacteria in the lungs, infection patterns, and CT scan findings in people with COPD, asthma, or bronchiectasis. It aims to understand these conditions better and may help guide future treatments.

NCT06858748Recruiting
Mucus in airways: asthma, COPD, and chronic cough study

This study is looking at how mucus builds up in the airways of people with asthma, COPD, or chronic cough. Researchers will also compare findings to healthy volunteers. The goal is to better understand these conditions and find new ways to help.

Vancouver, British Columbia
NCT06798077Recruiting
Chronic Lung Disease and Multiple Health Issues Study

This study follows people with chronic airway diseases like COPD, asthma, or bronchiectasis who were recently hospitalized for a worsening of their condition. It aims to understand how these diseases affect overall health and other medical problems over time.

Beijing, Beijing Municipality

Hear when a new Airway Inflammation trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.